Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:55 PM
Ignite Modification Date:
2025-12-24 @ 11:55 PM
NCT ID:
NCT00573651
Eligibility Criteria:
Inclusion Criteria:
* Female patients, age 9-26 years, with polyarticular JIA, pauciarticular JIA, and sero-negative arthritis.
Exclusion Criteria:
* Pregnancy
* Known allergy/sensitivity or any hypersensitivity to yeast or components of study drug or their formulation
* Systemic onset JIA with active systemic symptoms (systemic onset JIA with polyarticular features but no fever or rash may be included).
* Prior vaccination against HPV
* Known HPV infection
* Current or history of cervical cancer or cervical intraepithelial neoplasia (CIN).
Males are excluded from this study because Gardasil® is currently approved only for females.
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
9 Years
Maximum Age:
26 Years
Study:
NCT00573651
Study Brief:
Protocol Section:
NCT00573651